1801:TSEInnovent Biologics, Inc. Analysis
Data as of 2026-03-13 - not real-time
CN¥1.55
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The fund is trading at CNY 1.547, barely above its technical support of CNY 1.542 and well below the 52‑week high of CNY 2.263, suggesting a potentially attractive entry point. Technical indicators are mixed: the price sits under the 20‑day (1.593) and 50‑day (1.626) SMAs and the long‑term 200‑day SMA (1.790), confirming a bearish trend, while the RSI of 23.8 signals oversold conditions and the MACD histogram remains negative. Volume is stable, and the beta of 0.02 indicates minimal market‑wide price sensitivity, but the 30‑day volatility of ~9% and a historic max drawdown of over 31% highlight price swings. Despite a “Greed” sentiment reading (72.66 on the Fear‑Greed Index), the lack of any disclosed earnings, cash flow or dividend data leaves the fundamental valuation opaque.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Price near strong support level
- Oversold RSI indicating potential rebound
- Low beta reducing market‑wide exposure
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Continued bearish trend in moving averages
- Uncertainty due to absent earnings and cash flow data
- Moderate volatility and historical drawdown risk
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Fundamental opacity limits confidence in long‑term upside
- Regulatory environment for Chinese REITs remains uncertain
- Potential for steady income if future dividend policy is disclosed
Key Metrics & Analysis
Technical Analysis
TrendBearish
RSI23.8
SupportCN¥1.54
ResistanceCN¥1.62
MA 20CN¥1.59
MA 50CN¥1.63
MA 200CN¥1.79
MACDBearish
VolumeStable
Fear & Greed Index72.66
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta0.02
Volatility8.97%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.